TODD CLEMENTS: Open Payments
NPI 1275603581 · JONESBORO, AR. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$816 in 43 payments from 12 companies in 2025. Trend: 2023 $994 · 2024 $826 · 2025 $816
Food & beverage: $816
| Company | Payments | Amount |
|---|---|---|
| Janssen Pharmaceuticals, Inc | 10 | $196 |
| Otsuka America Pharmaceutical, Inc. | 10 | $164 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $86 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $75 |
| Axsome Therapeutics, Inc. | 3 | $70 |
| ABBVIE INC. | 4 | $64 |
| Neurocrine BioSciences, Inc. | 3 | $57 |
| Collegium Pharmaceutical, Inc. | 2 | $37 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 1 | $20 |
| Vanda Pharmaceuticals Inc. | 1 | $17 |
Products named: REXULTI, INVEGA SUSTENNA, TRINTELLIX, CAPLYTA, Auvelity, VRAYLAR, INGREZZA, SPRAVATO.
Industry payments across AR — which companies pay providers there.
